Gene · 1612
Papers4,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DAPK1 induces motor neuron apoptosis in hSOD1G93A-linked amyotrophic lateral sclerosis via regulating the Xiap/JNK pathway. | Mol Cell Neurosci | 2025 | 40669676 | PubTator, text mining | PubMed |
| Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer. | Cancers (Basel) | 2025 | 40563561 | PubTator, text mining | PubMed |
| Methylation of Tumor Suppressor Genes on Chromosome 9: Diagnostic Insights from a Nasopharyngeal Carcinoma in Vietnam. | Asian Pac J Cancer Prev | 2025 | 40542787 | PubTator, text mining | PubMed |
| Proteomics and Phosphoproteomics Characteristics of the Rhesus Macaque Lung Infected With Original SARS-CoV-2, Delta, and Omicron Variants. | J Med Virol | 2025 | 40536091 | PubTator, text mining | PubMed |
| Succinylation-related molecular activities in cancer: metabolic adaptations, immune landscape, and prognostic significance in colorectal cancer. | Front Immunol | 2025 | 40463370 | PubTator, text mining | PubMed |
| Innovative approaches for the treatment of stroke: a recent update. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 40439886 | PubTator, text mining | PubMed |
| Multifaceted role of zipper-interacting protein kinase beyond cell death: Implication of ZIPK dysregulation in neuronal and vascular injuries. | Pharmacol Res | 2025 | 40409521 | PubTator, text mining | PubMed |
Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high-grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models. | Cancer Commun (Lond) | 2025 | 40391786 | PubTator, text mining | PubMed |
| Focusing on DC cells to optimize the prediction of prognosis and innovative treatment strategies for colon cancer. | Sci Rep | 2025 | 40389562 | PubTator, text mining | PubMed |
| Corrigendum to "Bone mesenchymal stem cell-derived extracellular vesicles inhibit DAPK1-mediated inflammation by delivering miR-191 to macrophages" [Biochem. Biophys. Res. Commun. 598 (2022) 46981]. | Biochem Biophys Res Commun | 2025 | 40295148 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress-related prognosis signature characterizes the immune landscape and predicts the prognosis of colon adenocarcinoma. | Front Genet | 2025 | 40236629 | PubTator, text mining | PubMed |
| The Association between DNA Methylation Status and Epstein-Barr Virus Infection in Laryngeal Carcinomas. | Rom J Intern Med | 2025 | 40116629 | PubTator, text mining | PubMed |
| Editorial: Immunological precision therapeutics: integrating multi-omics technologies and comprehensive approaches for personalized immune intervention. | Front Immunol | 2025 | 40114915 | PubTator, text mining | PubMed |
| Immunohistochemical Expression of DAPK-1 in Oral Leukoplakia And Oral Squamous Cell Carcinoma: A Preliminary Study. | Cureus | 2025 | 40104466 | PubTator, text mining | PubMed |
| Impact of intermittent high-dose radon exposures on lung epithelial cells: proteomic analysis and biomarker identification. | J Radiat Res | 2025 | 40088196 | PubTator, text mining | PubMed |
| The IGF2BP2-circ-DAPK1 axis promotes high-glucose-induced ferroptosis of HUVECs by decreasing NQO1 expression. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40086519 | PubTator, text mining | PubMed |
| Circulating exosome-derived miR-191-5p is a novel therapeutic biomarker for radiotherapy in esophageal squamous cell carcinoma patients. | Esophagus | 2025 | 40064799 | PubTator, text mining | PubMed |
| Development and validation of a kinase-related gene signature as a novel diagnostic and prognostic model for prostate cancer. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39965532 | PubTator, text mining | PubMed |
| RNF146 Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating the Ubiquitination-Mediated Degradation of DAPK1 to Inhibit Ferroptosis. | Cardiovasc Toxicol | 2025 | 39953324 | PubTator, text mining | PubMed |
| Alpha-linolenic acid-mediated epigenetic reprogramming of cervical cancer cell lines. | Epigenetics | 2025 | 39895102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1612/papers?page=5